Uncategorized

Tortugas debuts with $106M and brain drugs from Hansoh, Eisai

Published

on

Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version